COVID‐19, androgens, and androgenic alopecia-Reference-Cited by-同舟云学术

COVID‐19, androgens, and androgenic alopecia

Published:2020-12-23 Issue:3 Volume:2 Page:146-153
ISSN:2637-7489
Container-title:Dermatological Reviews
language:en
Short-container-title:Dermatological Reviews

Author:

Wambier Carlos Gustavo¹^ORCID,Mehta Nina²,Goren Andy³^ORCID,Cadegiani Flavio A.⁴^ORCID

Affiliation:

1. Department of Dermatology Alpert Medical School of Brown University Providence Rhode Island USA

2. Brown University Providence Rhode Island USA

3. Applied Biology, Inc. Irvine California USA

4. Department of Clinical Endocrinology Federal University of Sao Paulo Sao Paulo Brazil

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/der2.50

Reference49 articles.

1. World Health Organization (WHO). Weekly epidemiological update—24 November. Weekly epidemiological updates. 2020.https://www.who.int/publications/m/item/weekly-epidemiological-update---24-november-2020. Accessed November 29 2020.

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?

4. Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

5. Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A fluorescence switch-off nanosensor for sensitive determination of the antiandrogen drug flutamide in pharmaceutical and environmental samples. Analytical method greenness, blueness, and whiteness assessment;Microchemical Journal;2024-09

2. Association of androgenetic alopecia with a more severe form of COVID-19 infection;Irish Journal of Medical Science (1971 -);2022-03-23

3. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics;Journal of Cosmetic Dermatology;2021-11-06

4. Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients;New Microbes and New Infections;2021-09

5. Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial;2021-07-02